Found: 77
Select item for more details and to access through your institution.
Clinical features associated with NeoRAS wild-type metastatic colorectal cancer A SCRUM-Japan GOZILA substudy.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50026-4
- By:
- Publication type:
- Article
Renal impairment as a risk factor for trifluridine/tipiracil-induced adverse events in metastatic colorectal cancer patients from the REGOTAS study.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-45244-7
- By:
- Publication type:
- Article
Sidedness-Dependent Prognostic Impact of Gene Alterations in Metastatic Colorectal Cancer in the Nationwide Cancer Genome Screening Project in Japan (SCRUM-Japan GI-SCREEN).
- Published in:
- Cancers, 2023, v. 15, n. 21, p. 5172, doi. 10.3390/cancers15215172
- By:
- Publication type:
- Article
Renal impairment as a risk factor for trifluridine/tipiracil-induced adverse events in metastatic colorectal cancer patients from the REGOTAS study.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-45244-7
- By:
- Publication type:
- Article
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study).
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 6, p. 1032, doi. 10.1038/s41416-023-02378-9
- By:
- Publication type:
- Article
Role of plasma angiogenesis factors in the efficacy of first‐line chemotherapy combined with biologics in RAS wild‐type metastatic colorectal cancer: Results from the GI‐SCREEN CRC‐Ukit study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 18, p. 18702, doi. 10.1002/cam4.6486
- By:
- Publication type:
- Article
A Phase II Trial of Trifluridine/Tipiracil in Combination with Cetuximab Rechallenge in Patients with RAS Wild-Type mCRC Refractory to Prior Anti-EGFR Antibodies: WJOG8916G Trial.
- Published in:
- Targeted Oncology, 2023, v. 18, n. 3, p. 369, doi. 10.1007/s11523-023-00963-9
- By:
- Publication type:
- Article
Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan.
- Published in:
- Gastric Cancer, 2023, v. 26, n. 1, p. 132, doi. 10.1007/s10120-022-01349-y
- By:
- Publication type:
- Article
Comprehensive geriatric assessment: Valuation and patient preferences in older Japanese adults with cancer.
- Published in:
- Journal of the American Geriatrics Society, 2023, v. 71, n. 1, p. 259, doi. 10.1111/jgs.18023
- By:
- Publication type:
- Article
multicentre retrospective study comparing site-specific treatment with empiric treatment for unfavourable subset of cancer of unknown primary site.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 12, p. 1416, doi. 10.1093/jjco/hyac143
- By:
- Publication type:
- Article
NOTCH gene alterations in metastatic colorectal cancer in the Nationwide Cancer Genome Screening Project in Japan (SCRUM-Japan GI-SCREEN).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 10, p. 2841, doi. 10.1007/s00432-022-04064-4
- By:
- Publication type:
- Article
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 9, p. 1450, doi. 10.1007/s10147-022-02208-7
- By:
- Publication type:
- Article
Phase IIb study of pembrolizumab combined with S‐1 + oxaliplatin or S‐1 + cisplatin as first‐line chemotherapy for gastric cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2814, doi. 10.1111/cas.15462
- By:
- Publication type:
- Article
Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A 10‐Item Frailty Index Based on a Comprehensive Geriatric Assessment (FI‐CGA‐10) in Older Adults with Cancer: Development and Construct Validation.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1751, doi. 10.1002/onco.13894
- By:
- Publication type:
- Article
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Patients with Esophageal Squamous Cell Carcinoma: Results from a Phase 1 Cohort in Asia.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 4, p. 447, doi. 10.1007/s11523-021-00810-9
- By:
- Publication type:
- Article
An Investigator-Initiated Phase 2 Study of Nivolumab Plus Low-Dose Ipilimumab as First-Line Therapy for Microsatellite Instability—High Advanced Gastric or Esophagogastric Junction Cancer (NO LIMIT, WJOG13320G/CA209-7W7).
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 805, doi. 10.3390/cancers13040805
- By:
- Publication type:
- Article
FMS‐like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancer.
- Published in:
- Cancer Science, 2021, v. 112, n. 1, p. 314, doi. 10.1111/cas.14693
- By:
- Publication type:
- Article
Multicenter Cohort Study to Assess the Association between Changes on Imaging and Outcome after Regorafenib Treatment (KSCC1603).
- Published in:
- Oncology, 2020, v. 98, n. 10, p. 719, doi. 10.1159/000507814
- By:
- Publication type:
- Article
Phase Ib study of FOLFOXIRI plus ramucirumab as first-line treatment for patients with metastatic colorectal cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Treatment strategies for neuroendocrine carcinoma of the upper digestive tract.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 5, p. 842, doi. 10.1007/s10147-020-01631-y
- By:
- Publication type:
- Article
Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 4, p. 614, doi. 10.1007/s10147-019-01600-0
- By:
- Publication type:
- Article
Multicenter phase II study of SOX plus trastuzumab for patients with HER2<sup>+</sup> metastatic or recurrent gastric cancer: KSCC/HGCSG/CCOG/PerSeUS 1501B.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer.
- Published in:
- Cancer Science, 2019, v. 110, n. 11, p. 3565, doi. 10.1111/cas.14198
- By:
- Publication type:
- Article
Hypoalbuminemia for the prediction of venous thromboembolism and treatment of direct oral anticoagulants in metastatic gastric cancer patients.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 5, p. 988, doi. 10.1007/s10120-019-00930-2
- By:
- Publication type:
- Article
Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: the JAVELIN Solid Tumor JPN trial.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 4, p. 817, doi. 10.1007/s10120-018-0903-1
- By:
- Publication type:
- Article
Efficacy and safety of ramucirumab plus modified FOLFIRI for metastatic colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 5, p. 508, doi. 10.1007/s10147-018-01391-w
- By:
- Publication type:
- Article
Phase I dose‐escalation study of capmatinib (INC280) in Japanese patients with advanced solid tumors.
- Published in:
- Cancer Science, 2019, v. 110, n. 4, p. 1340, doi. 10.1111/cas.13956
- By:
- Publication type:
- Article
Phase II trial of aflibercept with FOLFIRI as a second‐line treatment for Japanese patients with metastatic colorectal cancer.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 1032, doi. 10.1111/cas.13943
- By:
- Publication type:
- Article
A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2)
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 344, doi. 10.1007/s10120-018-0899-6
- By:
- Publication type:
- Article
Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phase III ABSOLUTE trial.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 1, p. 155, doi. 10.1007/s10120-018-0838-6
- By:
- Publication type:
- Article
A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Relationship Between Thymidine Kinase 1 Expression and Trifluridine/Tipiracil Therapy in Refractory Metastatic Colorectal Cancer: A Pooled Analysis of 2 Randomized Clinical Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Epithelial‐mesenchymal transition is activated in CD44‐positive malignant ascites tumor cells of gastrointestinal cancer.
- Published in:
- Cancer Science, 2018, v. 109, n. 11, p. 3461, doi. 10.1111/cas.13777
- By:
- Publication type:
- Article
The risk factors for oxaliplatin-induced peripheral sensory neuropathy and thrombocytopenia in advanced gastric cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Long‐term effects of crizotinib in ALK‐positive tumors (excluding NSCLC): A phase 1b open‐label study.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 5, p. 607, doi. 10.1002/ajh.25043
- By:
- Publication type:
- Article
Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 3, p. 464, doi. 10.1007/s10120-017-0759-9
- By:
- Publication type:
- Article
Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study.
- Published in:
- Oncologist, 2018, v. 23, n. 1, p. 7, doi. 10.1634/theoncologist.2017-0275
- By:
- Publication type:
- Article
Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
LJM716 in Japanese patients with head and neck squamous cell carcinoma or HER2-overexpressing breast or gastric cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase I study of NK105, a nanomicellar paclitaxel formulation, administered on a weekly schedule in patients with solid tumors.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 6, p. 750, doi. 10.1007/s10637-016-0381-4
- By:
- Publication type:
- Article
Aromatase inhibitors with or without luteinizing hormone-releasing hormone agonist for metastatic male breast cancer: report of four cases and review of the literature.
- Published in:
- Breast Cancer (13406868), 2016, v. 23, n. 6, p. 945, doi. 10.1007/s12282-016-0679-2
- By:
- Publication type:
- Article
Favorable control of advanced colon adenocarcinoma with severe bone marrow metastasis: A case report.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer.
- Published in:
- Gastric Cancer, 2016, v. 19, n. 3, p. 927, doi. 10.1007/s10120-015-0559-z
- By:
- Publication type:
- Article
Safety and tolerability of AZD5363 in Japanese patients with advanced solid tumors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A randomized, double-blind, placebo-controlled, Phase III study of pazopanib in patients with soft tissue sarcoma: results from the Japanese subgroup.
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 3, p. 248, doi. 10.1093/jjco/hyv184
- By:
- Publication type:
- Article
A phase II study of S-1, oxaliplatin, oral leucovorin, and bevacizumab combination therapy (SOLA) in patients with unresectable metastatic colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 547, doi. 10.1007/s00280-015-2825-5
- By:
- Publication type:
- Article